what are the roles sokal and hasford risk calculations have in prognosis and treatment of cml?
Published 8 years ago • 134 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
1:06
what is the sokal score and why is it important in cml?
-
9:58
dr. graeme fraser - cll patient prognosis
-
8:47
what is the clinical significance of co-mutational patterns in aml?
-
28:12
how far we’ve come: clinical research and sickle cell disease
-
4:13
andre schuh | what are the challenges in establishing new treatment response criteria in aml?
-
0:46
what are clinical trials? #aml
-
1:11:02
2019 cambridge dr follows presentation about cll at cll support conference
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
5:16
rolling submission for cilta-cel to treat relapsed/refractory multiple myeloma
-
4:33
cilta-cel effective in lenalidomide-refractory multiple myeloma
-
1:17
efficacy & safety of standard of care cilta-cel in r/r multiple myeloma
-
3:52
challenges of diagnosing ctcl (chapter 1)
-
5:48
how should decision makers assess the value of a medicine?
-
5:11
what to know about cancer clinical trials
-
3:00
ash choosing wisely® champions
-
45:09
rhr: the functional medicine approach to cancer, with lise alschuler
-
2:41
secondary hrqol domains in the karmma study of ide-cel in myeloma
-
2:30
the importance of collaboration in treating ctcl (chapter 7)
-
1:32
clinical trials: what is available and how do you get on them